Lattice Biologics plummets 25.0% on spectacular volume November 06, 2018 17:00 EST
CANADIAN DAILY STOCK REPORT
Lattice Biologics Ltd. (TSXV:LBL), Canada's 58th largest Biotechnology company by market cap, has plummeted 0.50c (25.0%) from its last trading session of November 05 to close at 1.50c. Compared with the S&P/TSX 60 Index which rose 4.7 points (0.5%) in the day, the relative price change was -25.5%. The fall was exacerbated by spectacular volume of 12.8 times the average daily volume of 38,184 shares. Its MCap is CAD1.4 million (US$1.1 million).